Heat shock protein-guided dual-mode CT/MR imaging of orthotopic hepatocellular carcinoma tumor
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heat shock protein-guided dual-mode CT/MR imaging of orthotopic hepatocellular carcinoma tumor
Authors
Keywords
-
Journal
Journal of Materials Chemistry B
Volume 6, Issue 9, Pages 1342-1350
Publisher
Royal Society of Chemistry (RSC)
Online
2018-02-05
DOI
10.1039/c7tb03076b
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A promising dual mode SPECT/CT imaging platform based on 99mTc-labeled multifunctional dendrimer-entrapped gold nanoparticles
- (2017) Shihui Wen et al. Journal of Materials Chemistry B
- Two-dimensional transition metal dichalcogenide nanomaterials for combination cancer therapy
- (2017) Linji Gong et al. Journal of Materials Chemistry B
- Targeted CT/MR dual mode imaging of human hepatocellular carcinoma using lactobionic acid-modified polyethyleneimine-entrapped gold nanoparticles
- (2017) Du Li et al. Journal of Materials Chemistry B
- Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma
- (2016) Ruizhi Wang et al. Scientific Reports
- Folate-targeted perfluorohexane nanoparticles carrying bismuth sulfide for use in US/CT dual-mode imaging and synergistic high-intensity focused ultrasound ablation of cervical cancer
- (2016) Di Zhou et al. Journal of Materials Chemistry B
- Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors
- (2015) Charan V. Devarakonda et al. BMC CANCER
- Cancer cells exploit adaptive mitochondrial dynamics to increase tumor cell invasion
- (2015) M Cecilia Caino et al. CELL CYCLE
- Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study
- (2015) Katrina S. Pedersen et al. INVESTIGATIONAL NEW DRUGS
- 17-Demethoxy-reblastatin, an Hsp90 inhibitor, induces mitochondria-mediated apoptosis through downregulation of Mcl-1 in human hepatocellular carcinoma cells
- (2015) Surong Zhao et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Development of a Mitochondria-Targeted Hsp90 Inhibitor Based on the Crystal Structures of Human TRAP1
- (2015) Changwook Lee et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Dendrimer-Assisted Formation of Fe3O4/Au Nanocomposite Particles for Targeted Dual Mode CT/MR Imaging of Tumors
- (2015) Hongdong Cai et al. Small
- Cell surface heparan sulfate proteoglycans are involved in the binding of Hsp90α and Hsp90β to the cell plasma membrane
- (2015) Anastasiya V Snigireva et al. Cell Adhesion & Migration
- Targeted CT imaging of human hepatocellular carcinoma using low-generation dendrimer-entrapped gold nanoparticles modified with lactobionic acid
- (2015) Yiyun Cao et al. Journal of Materials Chemistry B
- Mitochondrial Hsp90s suppress calcium-mediated stress signals propagating from mitochondria to the ER in cancer cells
- (2014) Hye-Kyung Park et al. Molecular Cancer
- Targeted CT/MR dual mode imaging of tumors using multifunctional dendrimer-entrapped gold nanoparticles
- (2013) Qian Chen et al. BIOMATERIALS
- Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors
- (2013) M. W. Saif et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies
- (2013) Erin Schenk et al. INVESTIGATIONAL NEW DRUGS
- Mitochondrial HSP90s and tumor cell metabolism
- (2012) Dario C. Altieri Autophagy
- Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications
- (2012) Shihui Wen et al. BIOMATERIALS
- Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions
- (2012) David S. Hong et al. CANCER TREATMENT REVIEWS
- Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
- (2012) L. Neckers et al. CLINICAL CANCER RESEARCH
- Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study
- (2011) Paul G. Richardson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
- (2011) S. Modi et al. CLINICAL CANCER RESEARCH
- Targeting HSP 90 Induces Apoptosis and Inhibits Critical Survival and Proliferation Pathways in Multiple Myeloma
- (2011) T. Khong et al. MOLECULAR CANCER THERAPEUTICS
- The Hsp90 inhibitor IPI-504 rapidly lowers EML4–ALK levels and induces tumor regression in ALK-driven NSCLC models
- (2011) E Normant et al. ONCOGENE
- HSP90 at the hub of protein homeostasis: emerging mechanistic insights
- (2010) Mikko Taipale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now